Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers
暂无分享,去创建一个
N. Yoo | S. Seo | S. Lee | Yoo Ri Kim | M. S. Kim | S. Song | J. Oh | M. Kang | Ji Youl Lee
[1] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.
[2] Andrey Korshunov,et al. Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.
[3] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[4] C. Prives,et al. p53: more research and more questions , 2006, Cell Death and Differentiation.
[5] S. H. Lee,et al. The JAK2 V617F mutation in de novo acute myelogenous leukemias , 2006, Oncogene.
[6] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.
[7] Jianping Ding,et al. Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity* , 2004, Journal of Biological Chemistry.
[8] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[9] W. Park,et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.
[10] M. Barbacid,et al. RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.
[11] K. Gibson,et al. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. , 2002, Cancer research.
[12] C. Arteaga,et al. HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer. , 2002, Seminars in oncology.
[13] C. Sawyers,et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.
[14] B. Geisbrecht,et al. The Human PICD Gene Encodes a Cytoplasmic and Peroxisomal NADP+-dependent Isocitrate Dehydrogenase* , 1999, The Journal of Biological Chemistry.
[15] M. Shin,et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer , 1999, Oncogene.
[16] K. Tipton,et al. Purification and properties of the nicotinamide-adenine dinucleotide phosphate-dependent isocitrate dehydrogenase from pig liver cytoplasm. , 1970, The Biochemical journal.